Clinical Research Directory
Browse clinical research sites, groups, and studies.
The MARVIN Chatbots to Provide Information for Different Health Conditions
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Summary
This research is a continuation of a usability study with the MARVIN chatbot. The investigators aim to adapt the MARVIN chatbot to open it to other health domains (e.g. breast cancer) and populations (e.g. pharmacists). Therefore, this protocol constitutes a master research protocol that will englobe different research projects with individual chatbots. The investigators adopt an adaptive platform trial design, which will allow flexibility in handling multiple interventions adapted to different populations while retaining the characteristics of a platform trial design allowing early withdrawal of ineffective trial arms based on interim data (implementation outcomes) and introduction of new trial arms.
Official title: A Master Research Protocol to Adapt and Evaluate an Artificial Intelligence Based Conversational Agent to Provide Information for Different Health Conditions: the MARVIN Chatbots
Key Details
Gender
All
Age Range
14 Years - Any
Study Type
INTERVENTIONAL
Enrollment
400
Start Date
2024-03-01
Completion Date
2034-12-31
Last Updated
2024-03-06
Healthy Volunteers
Yes
Interventions
MARVIN
Chatbot on Meta (Facebook) Messenger for HIV Patients
MARVIN-Pharma
Chatbot on Meta (Facebook) Messenger for community pharmacists
MARVINA
Chatbot on Meta (Facebook) Messenger for breast cancer patients
MARVIN-CHAMP
CHatbot to Assist the Management of Pediatric patients with infectious conditions (CHAMP)
Locations (2)
Centre hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, Canada
McGill University Health Centre (MUHC)
Montreal, Quebec, Canada